Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Procter & Gamble’s household brands—from Tide and Pampers to Gillette—generate billions across five global segments, and each quarter the company discloses exactly where that revenue comes from. If you have ever searched for “Procter & Gamble SEC filings explained simply,” this page is your direct route to the source data. Whether supply-chain costs shift or a new product line moves the needle, the underlying details live inside the filings we stream in real time.
Our platform automatically tags every form the moment it hits EDGAR. You can move from a single line item in the Procter & Gamble annual report 10-K simplified to the fresh numbers in the next Procter & Gamble quarterly earnings report 10-Q filing—all with AI-powered summaries that translate accounting jargon into plain language. Need to know when executives buy or sell? Receive alerts on Procter & Gamble Form 4 insider transactions real-time and review complete histories of Procter & Gamble executive stock transactions Form 4. Our AI further delivers “Procter & Gamble 8-K material events explained” so you grasp headline-moving announcements minutes after they post.
Investors use this hub to:
- Compare segment margins without combing through hundreds of pages
- Track currency impacts outlined in each 10-Q
- Monitor Procter & Gamble insider trading Form 4 transactions before earnings dates
- Review the Procter & Gamble proxy statement executive compensation for pay-for-performance alignment
- Dive into Procter & Gamble earnings report filing analysis prepared by our expert engine
If you are understanding Procter & Gamble SEC documents with AI for the first time or you are a seasoned analyst refining a model, our real-time updates, concise explanations, and complete coverage of every filing type keep you focused on decisions, not document hunting.
Procter & Gamble (PG) Form 144 notice: The filer reports a proposed sale of 47,232 shares of Procter & Gamble common stock, with an aggregate market value of $7,316,472.96, to be executed through Morgan Stanley Smith Barney LLC on the NYSE on 08/19/2025. The securities were acquired the prior day, 08/18/2025, as a Performance Stock Program Award from The Procter & Gamble Company, totaling 89,360 shares awarded and paid on 08/18/2025.
The filing states there were 2,342,371,488 shares outstanding at the time of the notice and reports no securities sold by the person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Procter & Gamble Form 144 notice reports a proposed sale of 714 shares of common stock, with an aggregate market value of $110,602.17, to be sold on the NYSE on or about 08/19/2025. The shares were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company and were paid for on 08/18/2025. The filing lists total shares outstanding of 2,342,371,488, indicating the sale is immaterial relative to the companys total float. The filer certifies they are unaware of any undisclosed material adverse information and provides standard Rule 144 representations regarding trading plans and compliance.
Form 144 notice for Procter & Gamble Company (PG). The filer notifies intent to sell 11,198 shares of Common Stock through Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 08/19/2025. The aggregate market value of the proposed sale is reported as $1,734,626.19 and the issuer's shares outstanding are shown as 2,342,371,488. The securities were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company; the filer lists acquiring 18,834 shares and indicates payment on 08/18/2025. No sales in the past three months are reported. The notice includes the standard representation about lack of undisclosed material adverse information.
Alexandra Keith, Chief Executive Officer – Beauty at The Procter & Gamble Company, has announced her intention to retire effective February 20, 2026, after more than 36 years with the company. Upon retirement she will enter the company’s standard Written Separation Agreement, which does not provide any cash severance and allows her to retain the remainder of a special equity award scheduled to vest in August 2026.
Per the report, all other equity awards will be retained or pro-rated as set out in the applicable Award Agreement. The disclosure does not include details about a successor or additional transition arrangements.
Procter & Gamble (PG) – Form 4 filed 08/07/2025. Chief Operating Officer Shailesh Jejurikar disclosed only acquisitions, no sales of company equity.
- Direct common stock: 9,982.2858 shares after the transactions.
- Indirect common stock: 3,301.9815 shares via retirement plan; 19,757 shares in the Sankhya S Jejurikar Revocable Trust; 17,849 shares in the Shailesh Jejurikar Trust.
- Derivative activity: Four separate grants of Restricted Stock Units (RSUs) and preferred-stock equivalents were reported: 31.0041 RSUs (02/18/25), 33.4003 RSUs (05/15/25), 0.3416 Series A preferred shares convertible into common stock (07/14/25), and 725 RSUs as a retirement award (08/07/25).
- All entries carry transaction code “A” (acquisition), and each grant was made at $0 cost as part of dividend-equivalent, retirement, or compensation programs.
- Total derivative holdings following the filing: 494.5685 + 527.9688 + 1,001.0622 + 725 ≈ 2,749 units/shares, split between direct and retirement-plan accounts.
No dispositions, option exercises, or open-market trades were reported; the filing merely updates ownership records and corrects small prior misstatements related to dividend-equivalent RSUs.
Filing: Form 4 filed 08/07/2025 by Marc S. Pritchard, Chief Brand Officer, for Procter & Gamble Co. (PG).
Non-derivative: Table I reports Common Stock entries including 173,134.4375 (marked D), 47,439.3762 (marked I — by Retirement Plan Trustees), 602 (I — by wife) and three entries of 107.032 (I — daughters ACP, CEP, NJP).
Derivative: Table II shows RSU-related acquisitions: 02/18/2025 — 207.3581 RSUs; 05/15/2025 — 223.3836 RSUs; 07/14/2025 — Series A Preferred 0.6323 (underlying 12,512.679 common stock) held by Retirement Plan Trustees; and 08/07/2025 — 1,253 RSUs. Explanations state RSUs include dividend equivalents and retirement-plan awards; Series A conversion/exercise price is the higher of $6.82 (post-split) or market price. The form is signed 08/07/2025 by attorney-in-fact Wednesday Shipp.
Procter & Gamble (PG) Form 4: Chief Legal Officer & Secretary Susan Street Whaley reported routine equity awards and updated share ownership as of 08/07/2025.
- Direct common-stock holding: 19,670.1407 shares.
- Indirect holding: 6,477.4515 shares via retirement plan trustee.
- New derivative grants: 772 Restricted Stock Units (RSUs) credited as a retirement award on 08/07/2025; no cash outlay.
- Dividend-equivalent RSUs: 6.1043 units (02/18/25) and 6.5759 units (05/15/25) added; both deliverable upon retirement.
- Series A preferred stock adjustment: 0.6322 units credited 07/14/25, convertible to common on distribution.
No shares were sold; all transactions are automatic, price-free allocations tied to dividend equivalents or retirement benefits. The officer now controls roughly 26,148 direct/indirect shares plus 1,833 RSU-equivalent derivatives—immaterial versus PG’s large float, indicating a neutral governance signal rather than a market-moving event.
On 08/07/2025 Procter & Gamble (PG) officer Sundar G. Raman, CEO of Fabric & Home Care, filed a Form 4 detailing only equity acquisitions and no dispositions.
- Direct common-stock ownership rises to 29,920.5607 shares.
- Indirect holdings via the retirement plan now total 8,366.3969 shares.
- New awards include 1,055 RSUs (retirement award) plus 41.6846 RSU dividend equivalents granted earlier in 2025, all recorded with code “A” at $0 price, reflecting plan-based grants rather than open-market buys.
- Derivative position: 1,417.28 RSUs directly and 2,061.8592 Series A preferred shares indirectly convertible to common.
The filing increases Raman’s beneficial ownership by roughly 1,097 new share equivalents (<~US$165k at $150/sh), a modest rise relative to PG’s market cap but directionally positive since no shares were sold.